Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin Against Pneumococci

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01353-09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Comparative Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Gemifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin Against Epidemiologically Defined Acinetobacter Baumannii Strains

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Comparative Study of the Mutant Prevention Concentrations of Sulfamethoxazole-Trimethoprim Alone and in Combination With Levofloxacin Against ≪i>Stenotrophomonas Maltophilia</I>

Advances in Infectious Diseases
2017English

Mutant Prevention Concentrations of Ciprofloxacin Against Urinary Isolates of Escherichia Coli and Klebsiella Pneumoniae

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2014English

Comparative in Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents Against Bloodstream Isolates of Gram-Positive Cocci

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

In Vitro Activities of Levofloxacin, Gatifloxacin, Moxifloxacin and Garenoxacin Against Bacteroides Fragilis Strains Evaluated by Kill Kinetics

Journal of Medical Microbiology
MedicineMicrobiology
2013English

Activity of Sitafloxacin Against Extracellular and Intracellular Staphylococcus Aureus in Vitro and in Vivo: Comparison With Levofloxacin and Moxifloxacin

Journal of Antibiotics
Drug DiscoveryPharmacology
2012English

Postantibiotic Effect and Postantibiotic Sub-Mic Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin Against 20 Pneumococci

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Protective Vaccination Against Pneumococci

Pneumologie
MedicinePulmonaryRespiratory Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy